Immunotherapy improves survival in advanced bladder cancer patients
An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of […]
» Read moreHome » Immunotherapy »
A recent study published in the journal Nature Medicine, led by researchers Todd Allen, Ph.D., a professor of Medicine at […] Acute lymphoblastic leukemia (ALL) is the most common cancer in children. This form of blood cancer is caused by malignant […] The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV […] Mismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, […] Even after decades of research, cancer remains difficult to treat, in part because of its ability to evade the body’s […] In a first on the quest to cure HIV, University of Pittsburgh Graduate School of Public Health scientists report today […] A treatment previously shown to clear the precancerous skin lesions called actinic keratosis now appears to reduce the chance that […] Colorectal cancer is the third leading cause of cancer-related deaths in both men and women. Despite significant advances in therapies […] Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable […]
Novel Dual CAR T cell immunotherapy holds promise for targeting the HIV reservoir
Research team tests novel immunotherapy against certain blood cancer cells
Immunotherapy drug found safe in treating cancer patients with HIV
Tumor mutations may predict response to immunotherapy
Innovative drug delivery improves effectiveness of cancer immunotherapy
Immunotherapy kicks and kills HIV by exploiting a common virus
Immunotherapy of precancerous skin lesions may prevent squamous cell carcinoma
The story of GARP: a potential target for cancer immunotherapy
Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
